Skip to main content
HUM
NYSE Finance

Humana Announces Preliminary Offering of Junior Subordinated Notes

Analysis by Wiseek.ai
Sentiment info
Neutral
Importance info
7
Price
$183.05
Mkt Cap
$22.082B
52W Low
$169.614
52W High
$315.348
Market data snapshot near publication time

summarizeSummary

Humana Inc. filed a preliminary prospectus supplement for an offering of fixed-to-fixed rate junior subordinated notes due 2056, intended for general corporate purposes including debt repayment.


check_boxKey Events

  • Preliminary Debt Offering Announced

    Humana announced a preliminary offering of fixed-to-fixed rate junior subordinated notes due 2056, with the aggregate principal amount and interest rate to be determined.

  • Subordinated Debt Structure

    The notes will rank junior in right of payment to all senior indebtedness and will be structurally subordinated to the indebtedness and other liabilities of the company's subsidiaries.

  • Option to Defer Interest Payments

    The company retains the option to defer interest payments on the junior subordinated notes for one or more periods of up to 10 consecutive years.

  • Use of Proceeds

    Net proceeds from the offering are intended for general corporate purposes, which may include the repayment of existing indebtedness, such as borrowings under its commercial paper program.


auto_awesomeAnalysis

This preliminary prospectus supplement signals Humana's intent to raise a substantial amount of capital through a debt offering. While the exact principal amount and interest rate are not yet disclosed, the offering of junior subordinated notes with an option to defer interest payments for up to 10 years indicates a financing structure that provides the company with significant financial flexibility, albeit at potentially higher risk for noteholders. The use of proceeds for general corporate purposes, including the repayment of existing commercial paper, is a standard practice to manage the balance sheet and liquidity. Investors should monitor the final terms of the offering for a complete assessment of its impact.

At the time of this filing, HUM was trading at $183.05 on NYSE in the Finance sector, with a market capitalization of approximately $22.1B. The 52-week trading range was $169.61 to $315.35. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed HUM - Latest Insights

HUM
Apr 29, 2026, 2:09 PM EDT
Filing Type: 10-Q
Importance Score:
8
HUM
Apr 29, 2026, 6:15 AM EDT
Source: Reuters
Importance Score:
8
HUM
Apr 29, 2026, 6:06 AM EDT
Filing Type: 8-K
Importance Score:
7
HUM
Apr 29, 2026, 6:04 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
HUM
Apr 27, 2026, 8:40 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
HUM
Mar 09, 2026, 4:22 PM EDT
Filing Type: 8-K
Importance Score:
7
HUM
Mar 06, 2026, 7:30 AM EST
Filing Type: DEF 14A
Importance Score:
7
HUM
Mar 05, 2026, 5:22 PM EST
Filing Type: FWP
Importance Score:
8
HUM
Mar 05, 2026, 8:38 AM EST
Filing Type: 424B5
Importance Score:
7
HUM
Feb 19, 2026, 2:26 PM EST
Filing Type: 10-K
Importance Score:
8